Automotive Interior Ambient Lighting Market size is expected to reach USD 4.59 billion by 2025 : Grand View Research, Inc.

 The global automotive interior ambient lighting market size is expected to reach USD 4.59 billion by 2025, according to a study conducted by Grand View Research, Inc., registering a 7.2% CAGR during the forecast period. The adoption of ambient lighting in automobiles is expected to increase due to rising awareness of energy-efficient lighting systems and growing sales of luxury vehicles equipped with navigation and infotainment systems.

Rising demand for conventional and green cars in the automotive industry is driving the growth of the automotive interior ambient lighting market. Automotive interior lighting positively influences space perception, internal appearance of vehicles, safety and comfort, and alerting and mood lighting depending on a driver’s mood. For instance, automotive interior lighting decreases a driver’s fatigue while driving at night and illuminates passenger compartment for reading. These benefits are expected to drive market growth. However, high costs of OE integration are expected to hinder the market over the forecast period.

The North America market is projected to expand at a CAGR of 5.4% over the forecast period. Prominent vendors in the market include OSRAM GmBH, Hella KGaA Hueck & Co., SCHOTT AG, DRÄXLMAIER Group, and Grupo Antolin.  

Full research report on automotive interior ambient lighting market analysis: https://www.grandviewresearch.com/industry-analysis/automotive-interior-ambient-lighting-market

Further key findings from the study suggest:

·         The automotive interior ambient lighting market is expected to register a CAGR of 7.2% over the forecast period

·         By vehicle type, the green cars segment is estimated to generate a revenue of USD 562.8 million by 2025

·         The footwell application segment generated the highest revenue of USD 1.46 billion in 2016. The dashboard application segment, on the other hand, is projected to exhibit the highest CAGR of 8.5% over the forecast period

·         Currently, North America is leading the market. However, Asia Pacific is expected to dominate the market by 2025 with the highest CAGR of 11.1% over the forecast period. This can be attributed to early adoption of the technology and growing sales of ultra-luxury vehicles in Asian countries such as India, China, and Japan

·         Prominent players in the market include OSRAM GmBH, Hella KGaA Hueck & Co., SCHOTT AG, DRÄXLMAIER Group, and Grupo Antolin.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/automotive-and-transportation

Grand View Research has segmented the global automotive interior ambient lighting market based on application, vehicle type, and region:

Automotive Interior Ambient Lighting Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Dashboard

·         Footwell

·         Doors

·         Others

Automotive Interior Ambient Lighting Vehicle Type Outlook (Revenue, USD Million, 2014 - 2025)

·         Conventional cars

·         Green cars

Automotive Interior Ambient Lighting Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

o    Mexico

o    Canada

·         Europe

o    U.K.

o    Germany

·         Asia Pacific

o    India

o    China

o    Japan

·         South America

o    Brazil

Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-automotive-interior-ambient-lighting-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: https://www.grandviewresearch.com/

Thyroid Gland Disorder Treatment Market size is expected to reach USD 2.6 billion by 2025 : Grand View Research, Inc

The global thyroid gland disorder treatment market size is expected to reach USD 2.6 billion by 2025, according to a new report by Grand View Research, Inc., and exhibit a 3.2% CAGR during the forecast period. Increase in prevalence of thyroid diseases around the globe is expected to drive demand for anti-thyroid drugs in the coming years. Hypothyroidism is one of the leading causes of hospitalization in U.S. Growing awareness about disease management amongst healthcare professionals and patients is another factor augmenting market growth. There are various private and public organizations working toward spreading awareness related to disease management, such as British Thyroid Foundation,The American Thyroid Association (ATA), and Thyroid Foundation of Canada.

Rising demand for these drugs has resulted in development of various generic equivalents of branded drugs to treat thyroid gland disorders. Generic drug manufacturers are focusing on strategies such as new product development, distribution channel enhancement, regional expansions, and collaborations with other companies for marketing their products to gain an edge over the competition. In addition, regulatory authorities that approve generic versions of branded drugs are working to overcome delays in product approvals and enable the availability of these drugs at a lower price. This is expected to boost the market over the forecast period.

Access Full research report on thyroid gland disorder treatment market analysis:
https://www.grandviewresearch.com/industry-analysis/thyroid-gland-disorder-treatment-market

Further key findings from the report suggest:

·         Hypothyroidism held the dominant revenue share in 2016 and is expected to maintain its position throughout the forecast period. On the other hand, hyperthyroidism is expected to witness steady growth on account of increase in incidence of Graves’ disease

·         The oral route is the most preferred or most frequently used route of administration owing to its convenience and simplicity, which helps improve patient compliance. The market is driven by the presence of a strong pipeline of oral anti-thyroid medications

·         Wholesalers accounted for the largest revenue share as of 2016 owing to increasing spending on outpatient prescription drugs along with overall healthcare expenditure. E-commerce is expected to witness lucrative growth in the coming years

·         The U.S. thyroid gland disorder treatment market is anticipated to exceed USD 1.03 billion by 2025 due to presence of sophisticated healthcare infrastructure, increased patient awareness, and high healthcare expenditure and R&D in drug discovery and development

·         Asian countries, especially India and China, are expected to observe remarkable growth in the coming years

·         The market is fragmented in nature, with presence of various large and small pharmaceutical players

·         Some of the key companies in the market areAbbott; AbbVie, Inc.; Merck KGaA; Mylan N.V.; Amgen Inc.; Pfizer, Inc.; GlaxoSmithKline plc.; and Lannett Company, Inc.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global thyroid gland disorder treatment market on the basis of indication, route of administration, distribution channel, and region:

Thyroid Gland Disorder Treatment Indication Outlook (Revenue, USD Million, 2014 - 2025)

·         Hypothyroidism

·         Hyperthyroidism

Thyroid Gland Disorder Treatment Route of Administration Outlook (Revenue, USD Million, 2014 - 2025)

·         Oral

·         Intravenous

·         Others

Thyroid Gland Disorder Treatment Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025)

·         Wholesalers/Distributors

·         Retail Chain

·         Online Distribution

·         Others

Thyroid Gland Disorder Treatment Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    U.K.

o    Germany

·         Asia Pacific

o    Japan

o    China

o    India

·         Latin America

o    Brazil

o    Mexico

·         Middle East & Africa

o    South Africa

Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-thyroid-gland-disorder-treatment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: https://www.grandviewresearch.com/

EPD Market size is expected to be valued at USD 502.8 million by 2025 : Grand View Research, inc

The global polyamide in electronic protection devices (EPD) market size is expected to be valued at USD 502.8 million by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 3.2% during the forecast period. Polyamide in EPD is a cost-effective and environment-friendly material. It offers performance advantages such as abrasion and heat resistance, which has been encouraging EPD manufacturers to replace other thermoset materials with polyamides in EPDs.

Rapid industrialization and technological advancements pertaining to infrastructure in developing nations are factors likely to boost the demand for EPDs, and, in turn, trigger demand for polyamides in application areas such as switch gears. Increasing utilization of electronic appliances, coupled with high repair cost incurred due to short circuits at high temperature, is also contributing to increasing adaptation of polyamides for shielding purposes in these appliances.

Polyamide manufacturers are progressively trying to align their product development strategies with ongoing trends in the electrical component market. Consumers are switching to low-cost products without compromising on safety and performance. Manufacturers of electrical protection devices are constantly experimenting with different types of materials such as polystyrene, polyester, and polybutylene. However, these efforts have failed to match the performance results offered by polyamide.

DuPont, DSM, and BASF are front-runners in terms of innovation directed to improve the characteristics and performance of polyamides catering to electrical switchgear and appliances industries. BASF and DuPont have wide and diverse product portfolios under the polyamide segment. The companies offer polyamide 6 and 66 under various brands with distinctive and crafted characteristics to suit EPD requirements.

Full research report on polyamide in electronic protection devices (EPD) market analysis:
https://www.grandviewresearch.com/industry-analysis/polyamide-in-electronic-protection-device-epd-market

Further key findings from the report suggest:

·         Polyamide in EPD is expected to generate a demand of 91.8 kilotons by the end of 2025

·         Asia Pacific recorded a consumption of 38.0 kilo tons of polyamide in 2016 to manufacture electronic protection devices and emerged as the largest as well as the fastest growing region

·         Asia Pacific is one of the regions where unsupervised blending of polyamides takes place. Blending of polyamide 6 and 66 is carried out in an unprescribed ratio, thereby altering the product demand dynamics

·         As of 2016, Germany was the largest market in Europe, accounting for over 33.0% of the market revenue as well as volume in the region. Germany is also the largest market in Europe for electrical and electronic products

·         In 2016, the MCB segment accounted for the largest share in the global market, closely followed by MCCB. India and China were the largest markets for polyamide in the EPD segment in the same year.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/plastics-polymers-and-resins

Grand View Research has segmented the global polyamide in EPD market on the basis of product, device, and region as follows:

Polyamide in EPD Product Outlook (Volume, Kilotons; Revenue, USD Million, 2014 - 2025)

·         PA 6

·         PA 66

·         PA 4,6

·         High Temperature Polyamide

·         Polyphthalamide (PPA)

Polyamide in EPD Device Outlook (Volume, Kilotons; Revenue, USD Million, 2014 - 2025)

·         MCB

·         MCCB

·         Relays

·         Contactors

·         Terminal Blocks

Polyamide in EPD Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S. 

·         Europe

o    Germany

o    U.K.

o    France

·         Asia Pacific

o    China

o    India

o    Japan

·         Central & South America

·         Middle East & Africa

Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-polyamide-in-electronic-protection-device-epd-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: https://www.grandviewresearch.com/

Medical Marijuana Market is expected to reach a value of USD 55.8 billion by 2025 : Grand View Research, Inc.

The global medical marijuana market is expected to reach a value of USD 55.8 billion by 2025, according to a new report by Grand View Research, Inc. It has been identified that, in 2016, Washington D.C. along with 28 states have legalized marijuana for medical uses. In 2016, states such as Arkansas, Florida, North Dakota, Ohio, and Pennsylvania were approved to use the drug in medical applications such as chemotherapies and pain management. The growing number of states and countries getting approval for using it in therapeutic applications is one of the crucial factors driving the demand over the coming few years.

The presence of several regulatory frameworks such as the Medical Marijuana Regulation and Safety Act is indicators of the present demand for the drug in the market. The regulatory framework requires every individual or the company associated such as growers, retail operators, and makers of processed pot products to obtain permission and an annual state license from 2018. An increasing number of issued licenses is also among factors that is expected to drive the market especially after 2018.

The increasing interest amongst the academic researchers and healthcare providers regarding the therapeutic uses of marijuana is among the significant factors, which is driving the market over the coming years. Some of its potential therapeutic values are suppression of vomiting & nausea, pain relief, and appetite stimulation. In addition, research states that marijuana is effective in providing relief to the patient suffering from HIV/AIDS, glaucoma, cancer, and multiple sclerosis. The growing number of therapeutic applications of the drug is one of the key factors that is propelling the market over the forecast period.

Full research report on medical marijuana market analysis: http://www.grandviewresearch.com/industry-analysis/medical-marijuana-market

Further key findings from the study suggest:

·         In 2015, chronic pain was the largest application segment owing to the presence of a huge patient base

·         The growing prevalence of chronic pain elevates the demand for the drug, thus expected to boost the medical marijuana for chronic pain management

·         The rapidly growing number of cannabis legalization in the U.S. is one of the key attributes for its increased demand in therapeutic and recreational uses, and thus anticipated to impel the market growth

·         Increasing investment in R&D & demand for cannabis in chemotherapy is expected to drive the growth in the Asia Pacific market

·         Some of the key players are Cara Therapeutics Inc.; CannaGrow Holdings, Inc.; Cannabis Sativa, Inc.; United Cannabis Corporation; GrowBlox Sciences, Inc.; GW Pharmaceuticals, plc; Lexaria Corp; International Consolidated Companies, Inc.

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the medical marijuana market by application and region:

Application Outlook (Market Revenue in USD Million, 2013 - 2025)

·         Chronic Pain

·         Arthritis

·         Migraine

·         Cancer

·         Others

Regional Outlook (Market Revenue in USD Million, 2013 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    Belgium

o    Croatia

o    Finland

o    France

o    Italy

o    Netherlands

o    Portugal

o    Romania

o    Switzerland

o    Czech Republic

o    Estonia

·         ROW

o    Israel

Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-medical-marijuana-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: https://www.grandviewresearch.com/